Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollment of the OPGx-LCA5 Phase 3 trial starting dosing in Q4 2026, and FDA clearance for OPGx-RDH12 with dosing planned for Q4 2026. The company also received FDA approval for phentolamine ophthalmic solution 0.75% for presbyopia, triggering a milestone payment. With $89 million in cash and funding agreements, Opus Genetics expects its cash runway to extend into 2029, supporting multiple clinical milestones and potential priority review vouchers.
Opus Genetics announced its Q3 2026 financial results and corporate updates. For readers following the health sector, here is Pluang's market snapshot as of Nov 10, 2026 18:42 WIB: out of 150 priced US health stocks, 85 rose and 56 fell. Notable movers include ABEO at USD 2.60 with 71% buy orders and a typical hold time of 24 days, DFTX at USD 36.18 with 100% buy orders and a 17-day hold time, and TVTX at USD 50.50 with an 8-day hold time.
Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...
The global paracetamol market is projected to grow from $12.05 billion in 2026 to $15.39 billion by 2032, with a CAGR of 4.12%. Growth is driven by increasing demand for pain and fever management, expanded access to over-the-counter medicines, and in...
ESET Research uncovered a sophisticated cyberespionage tool named Cereal, used by the Russia-aligned Turla group to spy on emails within Microsoft Exchange servers of governmental organizations in Kazakhstan and Romania. The tool stealthily collects ...
Registration is now open for Brand Licensing Expo 2027, scheduled for May 25-27 at Mandalay Bay, Las Vegas. The event, rebranded from Licensing Expo, features over 265 confirmed exhibitors including major brands like Amazon MGM Studios, Coca-Cola, an...
Nvidia's CEO Jensen Huang saw his shares lose $6.47 billion in one day following the company's board opening an independent investigation into foreign intelligence efforts targeting him. This caused Nvidia's stock to drop 4.3%, erasing about $192 bil...
